Am J Physiol Cell Physiol Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Cell Physiol 291: C185-C188, 2006. First published January 25, 2006; doi:10.1152/ajpcell.00644.2005
0363-6143/06 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/1/C185    most recent
00644.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Armstrong, D. D.
Right arrow Articles by Esser, K. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Armstrong, D. D.
Right arrow Articles by Esser, K. A.

REPORT

MUSCLE CELL BIOLOGY AND CELL MOTILITY

Expression of beta-catenin is necessary for physiological growth of adult skeletal muscle

Dustin D. Armstrong, Vicki L. Wong, and Karyn A. Esser

Department of Physiology, University of Kentucky, Lexington, Kentucky

Submitted 22 December 2005 ; accepted in final form 23 January 2006

ABSTRACT

Expression of beta-catenin is known to be important for developmental processes such as embryonic pattern formation and determination of cell fate. Inappropriate expression, however, has been linked to pathological states such as cancer. Here we report that expression of beta-catenin is necessary for physiological growth of skeletal muscle in response to mechanical overload. Conditional inactivation of beta-catenin was induced in control and overloaded muscle through intramuscular injection of adenovirus expressing Cre recombinase in beta-catenin floxed mice. Individual muscle fiber analysis was performed to identify positively transfected/inactivated cells and determine fiber cross-sectional area. The results demonstrate that fiber growth is completely inhibited when the beta-catenin expression is lost. This effect was cell autonomous, as fibers that did not exhibit recombination in the floxed mice grew to the same magnitude as infected/noninfected fibers from wild-type mice. These findings suggest that beta-catenin may be a primary molecular site through which multiple signaling pathways converge in regulating physiological growth.

hypertrophy; Wnt; overload


MODELS OF ONCOGENIC, developmental, and differentiated cell growth are characterized by activation of multiple signaling pathways. For example, the Wnt and phosphatidylinositol 3-kinase (PI3-kinase)/Akt (PKB) pathways are well-studied parallel signaling pathways, and studies in diverse cell types have determined that activation of either of these pathways is sufficient to promote cellular growth (5, 9, 13, 14).

Although these pathways are normally studied in isolation, it has become apparent that there are both synergistic and convergent interactions among pathways (15). One site of convergence in models of growth is with the expression of beta-catenin through inhibition of glycogen synthase kinase-3beta (GSK-3beta) (4, 7, 12). Subsequent to GSK-3beta inhibition, beta-catenin accumulates in the cytoplasm, where it can interact with cadherin at the membrane or it can be translocated to the nucleus (12, 15). In the nucleus, beta-catenin interacts with transcriptional coactivators, such as members of the T cell factor/lymphocyte enhancement factor-1 (Tcf/Lef-1) family and induces expression of growth-associated genes such as c-myc and cyclin D1 (13, 14). Overexpression of beta-catenin in myocytes and other nonmuscle cells has been shown to be sufficient to support cellular growth (9, 11, 13); however, it is not clear whether beta-catenin is a necessary molecular target for regulating growth in vivo.

This study used mechanical overload, a well-characterized physiological model, to induce in vivo growth in adult skeletal muscle. In this model, two of three synergistic muscles of the posterior hindlimb are removed, which induces a robust and reliable fiber growth in response to the increased loading in the remaining muscle (1, 2, 5, 8). Because beta-catenin is necessary for skeletal muscle development (6), inducible gene deletion was used to examine the role of beta-catenin in adult skeletal muscle growth. Conditional recombination of the beta-catenin gene was accomplished by injecting control (Cnt) and overloaded (Ovl) adult skeletal muscles of wild-type (WT) and floxed beta-catenin (BC) mice (Jackson Laboratory, Bar Harbor, ME) with an adenovirus expressing both Cre recombinase and green fluorescent protein (GFP) (Adv-Cre-GFP). We obtained an E1/E3-deleted, replication-incompetent, serotype 5 adenovirus-expressing Cre recombinase and GFP under control of the cytomegalovirus (CMV) promoter from the Baylor Vector Development Laboratory. All experimental procedures performed in this study were approved by the University of Kentucky Institutional Animal Care and Use Committee.

Adenovirus-mediated gene delivery has a low and variable rate of infection when used in mature skeletal muscle (10). The first set of experiments determined the efficacy of infection and recombination on inactivation of beta-catenin in skeletal muscle. Cnt and Ovl plantaris muscles were perfusion fixed (20 ml PBS and 4% Formalin) in vivo at 14 days after injection, sectioned, and immunohistochemically probed for GFP expression. As listed in Table 1 and seen in Fig. 1A, ~18% of examined muscle fibers in all groups were found to be GFP positive (GFP+) after Adv-Cre-GFP injection. Adenoviral infection is also known to induce an immune response, so hematoxylin and eosin-stained sections were compared to determine whether there was an increased immune response (Fig. 1B). As expected, all muscles injected with Adv-Cre-GFP exhibited regions of increased mononuclear cell infiltration, but there was no qualitative difference in the magnitude of the response when comparing injected Cnt vs. Ovl muscles at 14 days.


View this table:
[in this window]
[in a new window]
 
Table 1. Fiber number, CSA, and average muscle weight after Adv-Cre-GFP injection

 

Figure 1
View larger version (70K):
[in this window]
[in a new window]
 
Fig. 1. A: intramuscular injection of adenovirus expressing both Cre recombinase and green fluorescent protein (Adv-Cre-GFP) results in an average infection efficiency of ~18%. Fourteen days after injection (Adv-Inj) or noninjection (Non-Inj) and/or overload (Ovl), plantaris muscles were perfusion fixed, sectioned, and probed for GFP expression. On average, ~18% of examined fibers expressed detectable GFP levels after intramuscular injection (see Table 1). Cnt, control; BC, floxed beta-catenin; WT, wild type. B: intramuscular injection of Adv-Cre-GFP results in mild cell infiltration in all injected muscles. Fourteen days after injection/noninjection and/or overload, plantaris muscles were perfusion fixed, sectioned, and histologically stained with hematoxylin and eosin.

 
To verify successful recombination, genomic DNA was isolated and PCR was performed with primers directed against the recombined (floxdel) beta-catenin transgene. An appropriate-size floxdel product (631 bp) was detected in BC mice (Fig. 2A). Individual fiber analysis was performed immunohistochemically to determine whether beta-catenin gene recombination was associated with fiber infection. As shown in Fig. 2B, GFP+ muscle fibers were identified from injected BC Ovl muscle sections and these fibers stained negative for beta-catenin expression. This provides direct evidence that infected muscle fibers in BC mice did exhibit loss of beta-catenin expression. Collectively these experiments confirm that adenoviral injection of Cre recombinase mediated gene recombination of the beta-catenin locus, and loss of beta-catenin expression was detectable at the single-fiber level.


Figure 2
View larger version (37K):
[in this window]
[in a new window]
 
Fig. 2. A: intramuscular injection of Adv-Cre-GFP induces recombination in BC mice. Fourteen days after injection and/or overload, plantaris muscles were removed and genomic DNA was analyzed by PCR. Adv-Cre-GFP injection results in recombination of the beta-catenin transgene as demonstrated by detection of a floxdel PCR product (631 bp). HPRT, hypoxanthine guanine phosphoribosyl transferase. B: GFP+ fibers demonstrate a lack of beta-catenin expression in serial sections. Fourteen days after Adv-Cre-GFP injection and/or overload, plantaris muscles from BC mice were removed, serial sectioned, and probed for GFP and beta-catenin expression. An immunohistochemistry analysis of serial cross sections from BC Ovl mice reveals that GFP-expressing fibers (arrows) did not stain positive for beta-catenin expression. This was not seen in the injected WT Ovl muscle fibers.

 
To evaluate the functional role of beta-catenin in response to mechanical overload, single-muscle fiber analysis was done for cross-sectional area (CSA) of both infected/GFP+ and noninfected/GFP– fibers. Two x20 magnification images were captured from five individual muscles and analyzed for CSA with SPOT software by an investigator blinded to the genotype and muscle treatment group. Over 4,000 fibers were analyzed per group, and the results were statistically analyzed with a three-way analysis of variance (Table 1). The mosaic nature of the adenoviral infection in adult skeletal muscle means that infected fibers are located next to uninfected fibers in the same muscle. The power of this type of design is that quantitative comparisons can be made within muscles of a particular genotype and treatment group so that fibers that are exposed to the exact same physiological environment and only vary based on the presence or absence of inactivation can be compared.

The results from our analysis demonstrate that beta-catenin is necessary for in vivo growth of differentiated adult skeletal muscle fibers. The evidence to support this conclusion comes from quantitative comparisons of data in Table 1 and is illustrated in Fig. 3. We found that, unlike the ~60% increase in CSA seen in Ovl WT mice (P < 0.05), there is no difference in fiber CSA between Cnt and Ovl GFP+ fibers in BC mice.


Figure 3
View larger version (14K):
[in this window]
[in a new window]
 
Fig. 3. GFP+ muscle fibers from BC mice demonstrate an inhibition of growth after overload. Fourteen days after Adv-Cre-GFP injection and/or overload, fiber cross-sectional area (CSA) was quantified as described in the text. A: there is no significant difference in average fiber CSA across all groups, infected (GFP+) and noninfected (GFP–) for both WT and BC genotypes. B: CSA of GFP+ fibers in BC Ovl+ fibers are significantly smaller compared with CSA of fibers from WT Ovl+ (819 ± 127 vs. 1,172 ± 157 µm2; *P < 0.0001) and BC Ovl– fibers within the same muscle section (819 ± 127 vs. 1,390 ± 241 µm2; {star}P < 0.0001). Furthermore, GFP+ fibers from BC Ovl (B) are not significantly different from GFP+ fibers of BC Cnt muscle (A). Values represent means ± SE (see numbers in Table 1).

 
This effect of loss of beta-catenin on the growth response is fiber autonomous, as the neighboring nontransfected/GFP– fibers in Ovl BC mice were not different in size from GFP+/GFP– fibers in Ovl WT mice. In addition, the GFP– fibers in Ovl BC mice were significantly larger than all fibers in Cnt BC mice. We were surprised that there was no detectable growth in the recombined/GFP+ fibers of Ovl BC mice. It has been well established that the IGF-I/PI3-kinase/Akt pathway is activated in this model of mechanical overload, and this pathway would still be intact in the beta-catenin knockout/GFP+ fibers (1, 3, 5, 16). Thus our findings suggest that either 1) enhanced expression of beta-catenin is a common molecular target at which multiple signaling pathways converge in directing skeletal muscle growth or 2) beta-catenin can act upstream of PKB signaling. Although we cannot rule out option 2 with the data presented, to date there is no evidence suggesting that beta-catenin acts upstream to regulate PKB signaling.

In summary, the results of this study demonstrate that expression of beta-catenin is absolutely necessary for in vivo skeletal muscle fiber growth. In addition, the fiber-autonomous effect of loss of beta-catenin expression in response to overload suggests that beta-catenin may be a fundamental molecular site through which multiple signaling pathways converge and synergistically regulate muscle fiber growth. Depending on whether the goal is to promote cell growth, as in skeletal muscle of the aging, or to inhibit growth, in the case of cancer, these findings implicate the manipulation of beta-catenin levels as a likely target for therapeutic design.

GRANTS

This work was supported by National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant AR-45617 (to K. A. Esser).

ACKNOWLEDGMENTS

We thank Dr. A. Stromberg for assistance with the statistical analysis and Dr. J. McCarthy for helpful discussions.

Present address for D. D. Armstrong: Novartis Institutes for BioMedical Research, Inc., Models of Disease Center, Epigenetics Dept., 250 Massachusetts Ave., 4C-341, Cambridge, MA 02139 (e-mail: dustin.armstrong{at}novartis.com).

FOOTNOTES


Address for reprint requests and other correspondence: K. A. Esser, Dept. of Physiology, MS567 Medical Center, 800 Rose St., Lexington, KY 40536-0298 (e-mail: karyn.esser{at}uky.edu)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

REFERENCES

1. Adams GR and Haddad F. The relationships among IGF-1, DNA content, and protein accumulation during skeletal muscle hypertrophy. J Appl Physiol 81: 2509–2516, 1996.[Abstract/Free Full Text]

2. Armstrong DD and Esser KA. Wnt/beta-catenin signaling activates growth-control genes during overload-induced skeletal muscle hypertrophy. Am J Physiol Cell Physiol 289: C853–C859, 2005.[Abstract/Free Full Text]

3. Barton-Davis ER, Shoturma DI, and Sweeney HL. Contribution of satellite cells to IGF-I induced hypertrophy of skeletal muscle. Acta Physiol Scand 167: 301–305, 1999.[CrossRef][Web of Science][Medline]

4. Bax B, Carter PS, Lewis C, Guy AR, Bridges A, Tanner R, Pettman G, Mannix C, Culbert AA, Brown MJ, Smith DG, and Reith AD. The structure of phosphorylated GSK-3beta complexed with a peptide, FRATtide, that inhibits beta-catenin phosphorylation. Structure 9: 1143–1152, 2001.[Medline]

5. Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R, Zlotchenko E, Scrimgeour A, Lawrence JC, Glass DJ, and Yancopoulos GD. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 3: 1014–1019, 2001.[CrossRef][Web of Science][Medline]

6. Cossu G and Borello U. Wnt signaling and the activation of myogenesis in mammals. EMBO J 18: 6867–6872, 1999.[CrossRef][Web of Science][Medline]

7. Desbois-Mouthon C, Cadoret A, Blivet-Van Eggelpoel MJ, Bertrand F, Cherqui G, Perret C, and Capeau J. Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation. Oncogene 20: 252–259, 2001.[CrossRef][Web of Science][Medline]

8. Goldberg AL, Etlinger JD, Goldspink DF, and Jablecki C. Mechanism of work-induced hypertrophy of skeletal muscle. Med Sci Sports 7: 185–198, 1975.[Web of Science][Medline]

9. Haq S, Michael A, Andreucci M, Bhattacharya K, Dotto P, Walters B, Woodgett J, Kilter H, and Force T. Stabilization of beta-catenin by a Wnt-independent mechanism regulates cardiomyocyte growth. Proc Natl Acad Sci USA 100: 4610–4615, 2003.[Abstract/Free Full Text]

10. Huard J, Lochmuller H, Acsadi G, Jani A, Holland P, Guerin C, Massie B, and Karpati G. Differential short-term transduction efficiency of adult versus newborn mouse tissues by adenoviral recombinants. Exp Mol Pathol 62: 131–143, 1995.[CrossRef][Web of Science][Medline]

11. Kim KI, Cho HJ, Hahn JY, Kim TY, Park KW, Koo BK, Shin CS, Kim CH, Oh BH, Lee MM, Park YB, and Kim HS. beta-Catenin overexpression augments angiogenesis and skeletal muscle regeneration through dual mechanism of vascular endothelial growth factor-mediated endothelial cell proliferation and progenitor cell mobilization. Arterioscler Thromb Vasc Biol 26: 91–98, 2006.[Abstract/Free Full Text]

12. Logan CY and Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20: 781–810, 2004.[CrossRef][Web of Science][Medline]

13. Moon RT, Kohn AD, De Ferrari GV, and Kaykas A. WNT and beta-catenin signalling: diseases and therapies. Nat Rev Genet 5: 691–701, 2004.[CrossRef][Medline]

14. Nelson WJ and Nusse R. Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303: 1483–1487, 2004.[Abstract/Free Full Text]

15. Nusse R. Cell biology: relays at the membrane. Nature 438: 747–749, 2005.[CrossRef][Medline]

16. Rommel C, Bodine SC, Clarke BA, Rossman R, Nunez L, Stitt TN, Yancopoulos GD, and Glass DJ. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat Cell Biol 3: 1009–1013, 2001.[CrossRef][Web of Science][Medline]




This article has been cited by other articles:


Home page
J. Physiol.Home page
M. G. MacKenzie, D. L. Hamilton, J. T. Murray, P. M. Taylor, and K. Baar
mVps34 is activated following high-resistance contractions
J. Physiol., January 1, 2009; 587(1): 253 - 260.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
A. Perez-Ruiz, Y. Ono, V. F. Gnocchi, and P. S. Zammit
{beta}-catenin promotes self-renewal of skeletal-muscle satellite cells
J. Cell Sci., May 1, 2008; 121(9): 1373 - 1382.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/1/C185    most recent
00644.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Armstrong, D. D.
Right arrow Articles by Esser, K. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Armstrong, D. D.
Right arrow Articles by Esser, K. A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.